Skip to content

Clinical trials

Cardiovascular Diseases trials in Peru

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Country / region: Peru Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20071
20082
20092
20102
20122
20151
20171
20183
20191
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Takeda3
AstraZeneca2
GlaxoSmithKline2
CSL Behring1
Emory University1
Hamilton Health Sciences Corporation1
NYU Langone Health1
National Institute of Allergy and Infectious Diseases (NIAID)1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases18
Atherosclerosis5
Heart Diseases5
Myocardial Infarction4
Stroke4
Acute Coronary Syndrome3
Coronary Disease3
Hypertension3
Coronary Artery Disease2
Diabetes Mellitus, Type 22

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.